AKT2 and neoplasm: Thus, we hypothesized that targeting AKT2 could be effective in multiple levels; it may diminish invasiveness and transformative potential of CSC, to revert the mesenchymal phenotype of aggressive tumor cells back to a more epithelial type, and to reduce of the incidence of CTCs in the bloodstream and the concomitant opportunity for metastatic spread.